Siemens Fonds Invest GmbH Has $480,000 Position in Colgate-Palmolive (NYSE:CL)

Siemens Fonds Invest GmbH decreased its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 78.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,282 shares of the company's stock after selling 18,842 shares during the period. Siemens Fonds Invest GmbH's holdings in Colgate-Palmolive were worth $480,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC purchased a new position in Colgate-Palmolive during the fourth quarter worth $26,000. Centricity Wealth Management LLC purchased a new position in Colgate-Palmolive during the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $32,000. Briaud Financial Planning Inc purchased a new position in Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 0.3%

NYSE:CL traded down $0.32 during trading hours on Wednesday, hitting $91.67. 4,569,171 shares of the stock traded hands, compared to its average volume of 4,653,187. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The firm has a market cap of $74.29 billion, a price-to-earnings ratio of 26.04, a PEG ratio of 4.20 and a beta of 0.39. The firm has a 50 day moving average price of $91.71 and a 200 day moving average price of $91.26.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. During the same period in the previous year, the firm posted $0.86 earnings per share. The firm's revenue was down 3.0% on a year-over-year basis. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive declared that its Board of Directors has authorized a share buyback plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board believes its shares are undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were paid a $0.52 dividend. The ex-dividend date of this dividend was Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a yield of 2.27%. Colgate-Palmolive's payout ratio is 58.76%.

Wall Street Analyst Weigh In

CL has been the subject of several recent research reports. Morgan Stanley lowered their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. UBS Group boosted their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research report on Monday, February 3rd. Finally, StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $102.12.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.